Spanks
Guest
Spanks
Guest
What is up with all of the reps leaving the mighty Aptalis? Could it be the expired pipeline of products, the launch or relaunch of products that are beyond their time, the management and marketing teams that constantly drop the ball, or, is it simply the pay that us sales reps receive?
I'd say that it is all of the above. When is the last time you received a pay raise? Granted, there are some pharma companies that are laying employees off, but we are doing the exact opposite. And no, the recalculation of our Rectiv bonuses does not count. Unrealistic reach of sales goals if I have ever seen one. Selling a product that was once popular 30 years ago and has since been replaced with a better form of therapy is probably not the best product to purchase and launch to physicians that stopped writing this product because of bad side effects many moons ago.
I'm not a genius by any means, but I would say that the pay and future of our company are to blame for reps leaving. There are many companies out there picking out reps from our line up, one by one. Aptalis, once a small and prosperous company, is being overrun by big pharma mentality. "Novartis, ooops, I mean Aptalis. Silly Me." Competitive pay and an opportunity to move through the company leveling would be great.
Do I need to even get into the overpaid product of Zenpep and I cant wait to see how Ultresa and Viokace fit into this marketing strategy. Kiss your Zenpep bonuses goodbye because this is all a special plan to make the goals even that much more impossible to achieve. Ultresa vs. Zenpep vs. Creon vs. Viokace. I can't wait to sell competing products to physicians and then be expected to grow my PE business by 80%. Well, we do have 3 of the 5 PE's on the market.
Thanks
Spanks
I'd say that it is all of the above. When is the last time you received a pay raise? Granted, there are some pharma companies that are laying employees off, but we are doing the exact opposite. And no, the recalculation of our Rectiv bonuses does not count. Unrealistic reach of sales goals if I have ever seen one. Selling a product that was once popular 30 years ago and has since been replaced with a better form of therapy is probably not the best product to purchase and launch to physicians that stopped writing this product because of bad side effects many moons ago.
I'm not a genius by any means, but I would say that the pay and future of our company are to blame for reps leaving. There are many companies out there picking out reps from our line up, one by one. Aptalis, once a small and prosperous company, is being overrun by big pharma mentality. "Novartis, ooops, I mean Aptalis. Silly Me." Competitive pay and an opportunity to move through the company leveling would be great.
Do I need to even get into the overpaid product of Zenpep and I cant wait to see how Ultresa and Viokace fit into this marketing strategy. Kiss your Zenpep bonuses goodbye because this is all a special plan to make the goals even that much more impossible to achieve. Ultresa vs. Zenpep vs. Creon vs. Viokace. I can't wait to sell competing products to physicians and then be expected to grow my PE business by 80%. Well, we do have 3 of the 5 PE's on the market.
Thanks
Spanks